Aptevo Therapeutics Stock Forecast

Stock Price Forecast

There have not been any analyst price target forecasts for Aptevo Therapeutics in the last 12 months.

Price Target: n/a

Analyst Consensus: n/a

Target	Low	Average	Median	High
Price	n/a	n/a	n/a	n/a
Change	n/a	n/a	n/a	n/a

Analyst Ratings

There are currently no analyst ratings available for Aptevo Therapeutics.

Recommendation Trends

Rating	Apr '24	May '24	Jun '24	Jul '24	Aug '24
Strong Buy	1	1	1	1	1
Buy	1	1	1	1	1
Hold	0	0	0	0	0
Sell	0	0	0	0	0
Strong Sell	0	0	0	0	0
Total	2	2	2	2	2

Latest Forecasts

Analyst	Firm	Rating	Rating	Action	Price Target	Upside	Date
Jonathan Aschoff Roth MKM	Roth MKM	Strong Buy Maintains $199,800 → $106,560	Strong Buy	Maintains	$199,800 → $106,560	+1,991,675.70%	Sep 23, 2024
Edward Tenthoff Piper Sandler	Piper Sandler	Buy Maintains $40,439,520 → $11,721,600	Buy	Maintains	$40,439,520 → $11,721,600	+219,095,227.10%	May 13, 2022
Jonathan Aschoff Roth Capital	Roth Capital	Strong Buy Maintains $37,509,120 → $29,304,000	Strong Buy	Maintains	$37,509,120 → $29,304,000	+547,738,217.76%	May 28, 2021
Edward Tenthoff Piper Sandler	Piper Sandler	Buy Maintains $18,754,560 → $40,439,520	Buy	Maintains	$18,754,560 → $40,439,520	+755,878,778.50%	Nov 11, 2020
Jonathan Aschoff Roth Capital	Roth Capital	Strong Buy Initiates $98,461,440	Strong Buy	Initiates	$98,461,440	+1,840,400,647.66%	Apr 11, 2018

More Analyst Ratings

Financial Forecast

Revenue This Year

n/a

Revenue Next Year

n/a

EPS This Year

-21.41

from -82.30

EPS Next Year

-19.02

from -21.41

Fiscal Year	FY 2021	FY 2022	FY 2023	FY 2024	FY 2025	FY 2026	FY 2027
Period Ending	Dec 31, 2021	Dec 31, 2022	Dec 31, 2023	Dec 31, 2024	Dec 31, 2025	Dec 31, 2026	Dec 31, 2027
Revenue	12.29M	3.11M	-	-	-	-	-
Revenue Growth	185.26%	-74.67%	-	-	-	-	-
EPS	-	-	-	-	-82.30	-21.41	-19.02
EPS Growth	-	-	-	-	-	-	-
Forward PE	-	-	-	-	-	-	-
No. Analysts	-	-	-	-	-	3	3

Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue	2026	2027
High	n/a	n/a
Avg	n/a	n/a
Low	n/a	n/a

Revenue Growth

Revenue Growth	2026	2027
High	-	-
Avg	-	-
Low	-	-

EPS Forecast

EPS	2026	2027
High	-22.04	-19.58
Avg	-21.41	-19.02
Low	-20.57	-18.28

EPS Growth

EPS Growth	2026	2027
High	-	-
Avg	-	-
Low	-	-

Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data sources.